Page 3,289«..1020..3,2883,2893,2903,291..3,3003,310..»

My Ulcerative Colitis Diet – Video

Posted: Published on November 1st, 2014

My Ulcerative Colitis Diet Just sharing my Colitis food dos and don'ts! 🙂 This was recorded this morning! (10-28-14) ~~~ My Facebook page: https://www.facebook.com/jenniesymsickart?re... By: emokitten6871 … Continue reading

Posted in Ulcerative Colitis | Comments Off on My Ulcerative Colitis Diet – Video

Managing Ulcerative Colitis Naturally: Outlook & Perspective – Video

Posted: Published on November 1st, 2014

Managing Ulcerative Colitis Naturally: Outlook Perspective This might be the most important element to managing Ulcerative Colitis (or any chronic disease) naturally. (open me for goodies!) My background with UC: http://youtu.be/ojdrFyOcxKk Nick... By: SarahBethYoga … Continue reading

Posted in Ulcerative Colitis | Comments Off on Managing Ulcerative Colitis Naturally: Outlook & Perspective – Video

Justin Mirigliani repping 260lbs on the Bench! Never Surrender! Fighting Ulcerative Colitis! – Video

Posted: Published on November 1st, 2014

Justin Mirigliani repping 260lbs on the Bench! Never Surrender! Fighting Ulcerative Colitis! Justin Mirigliani training for the game against the Flyers Alumni on January 10, 2015 in Aston, PA. Not quite where I want to be, but getting there! For more information go to: http://www.checkmatescharit... By: Justin Mirigliani … Continue reading

Posted in Ulcerative Colitis | Comments Off on Justin Mirigliani repping 260lbs on the Bench! Never Surrender! Fighting Ulcerative Colitis! – Video

TSRI's MS Drug Also Shows Promise In Ulcerative Colitis

Posted: Published on November 1st, 2014

By Estel Grace Masangkay The Scripps Research Institute (TSRI) reported that results from the Phase 2 study of RPC1063, a drug discovered at the Institute, show RPC1063s potential in the treatment of ulcerative colitis (UC). RPC1063 is a sphingosine 1-phosphate 1 receptor (S1P1R) small molecule modulator drug candidate being investigated for immune indications. These include relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD), under which ulcerative colitis is categorized along with Crohns disease. RPC1063 was derived from a screening hit conducted at the National Institutes of Health molecular library at Scripps Florida's Molecular Screening Center, after which it was licensed to Receptos for further development. Receptos reported positive results from a Phase 2 trial of the drug in relapsing multiple sclerosis earlier this year. The double blind, randomized, placebo-controlled TOUCHSTONE trial investigated the safety, tolerability, and efficacy of RPC1063 in patients with UC. The drug met the trials primary endpoint, which was proportion of patients in clinical remission at week 8 compared to placebo. Secondary endpoints were also met, including clinical response, change from baseline, and mucosal improvement on endoscopy. The company said it will present detailed results of the trial at an upcoming major scientific meeting. We are … Continue reading

Posted in Ulcerative Colitis | Comments Off on TSRI's MS Drug Also Shows Promise In Ulcerative Colitis

Treatment for Becker’s Muscular Dystrophy – Video

Posted: Published on November 1st, 2014

Treatment for Becker's Muscular Dystrophy Boy from Gujarat shows improvement in just 6 months after treatment for Becker's Muscular Dystrophy by dr alok sharma, After Treatment 1. Stamina has improve... By: Neurogen Brain and Spine Institute … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Treatment for Becker’s Muscular Dystrophy – Video

High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy

Posted: Published on November 1st, 2014

WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Eating a low-carb, high-fat diet could help control epilepsy that is difficult to treat, according to new research. A review of five studies found that a ketogenic, or modified Atkins diet, that focuses on foods like bacon, eggs, heavy cream, butter, fish and green vegetables, could help reduce seizures in adults whose condition doesn't improve with medication. "We need new treatments for the 35 percent of people with epilepsy whose seizures are not stopped by medications," study co-author Dr. Pavel Klein explained in an American Academy of Neurology news release. "The ketogenic diet is often used in children, but little research has been done on how effective it is in adults." In conducting the review, the researchers analyzed five studies on the ketogenic diet involving 47 people. The ketogenic diet consists of a ratio of fat to protein/carbohydrate of three or four to one. The researchers also reviewed five more studies on the modified Atkins diet, which included 85 people. The modified Atkins diet has a one-to-one fat to protein/carbohydrate ratio by weight. The researchers found that 32 percent of the patients on the ketogenic diet and 29 percent of those following the … Continue reading

Comments Off on High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy

Scientists link 60 genes to autism risk

Posted: Published on November 1st, 2014

By Danielle Ryan, Special to CNN updated 2:46 PM EDT, Thu October 30, 2014 Genetic research has been used to treat all kinds of disorders and diseases. STORY HIGHLIGHTS (CNN) -- Researchers have found dozens of new genes that may play a role in causing autism, according to two studies published Wednesday in the medical journal Nature. Scientists identified 60 genes with a greater than 90% chance of increasing a child's autism risk. Previous research has yielded only 11 genes that had been confirmed with this level of certainty. Though other studies have shown the importance of genetics in the development of autism, experts say these new studies zero in on the exact nature of the genetic mutations that cause the disorder. The researchers say these genes appear to be clustering around three sets of key biological functions. The first set focuses on the development of synapses in the brain, which are responsible for all kinds of communication between nerves. The second set is responsible for the creation of genetic instructions, and the third is responsible for DNA packaging within cells. Each of these functions could have an effect on the individual that would cause the traits commonly associated with … Continue reading

Comments Off on Scientists link 60 genes to autism risk

Cell Expansion Market Worth $14.8 Billion by 2019

Posted: Published on November 1st, 2014

DALLAS, October 29, 2014 /PRNewswire/ -- According to the new market research report The"Cell Expansion Marketby Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Expansion Market along with the estimates and forecasts of the revenue and share analysis. Browse 149 Market Data Tables and 56 Figures spread through 224 Pages and in-depth TOC on"Cell Expansion Market" http://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html Early buyers will receive 10% customization on this report. The global Cell Expansion Market is expected to reach $14.8 Billion by 2019 from $6.0 Billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The report segments this market on the basis of product, cell type, application, and end user. Among various applications, the regenerative medicines is expected to account for the largest share in 2014 and is expected to account for the fastest-growing segment in the cell expansion market, owing to technological advancement due to which new products are being launched in the market. Furthermore, rising investments … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Cell Expansion Market Worth $14.8 Billion by 2019

Stroke – Treatment – Heart and Stroke Foundation of Canada

Posted: Published on November 1st, 2014

In the last few years, important new advances have been made in stroke treatment. However, these new treatments must bestarted within a few hours of the onset of symptoms in order to be effective. That's why it's so important to recognize the warning signs of a stroke as soon as they appear and call 9-1-1 or your local emergency number for immediate medical assistance. There are three main emergency treatments for stroke: tPA, surgery and non-surgical procedures. The treatment youreceive will depend onthe type of stroke you have, howserious your stroke was, your age and general health, and how soon you arrive at the hospital. Whatever treatment you receive, remember that making healthy lifestyle choices to change your risk factors for stroke is an important part of your treatment and recovery. tPA (tissue plasminogen activator) Thrombolytic drugs such as tPA are often called clot busters. tPA is short for tissue plasminogen activator and can only be given to patients who are having a stroke caused by a blood clot (ischemic stroke). It can stop a stroke by breaking up the blood clot. It must be given as soon as possible and within 4 hours after stroke symptoms start.* Receiving tPA … Continue reading

Comments Off on Stroke – Treatment – Heart and Stroke Foundation of Canada

Stem Cell Therapy BACKSTAGE – Video

Posted: Published on November 1st, 2014

Stem Cell Therapy BACKSTAGE By: … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy BACKSTAGE – Video

Page 3,289«..1020..3,2883,2893,2903,291..3,3003,310..»